
Ask a doctor about a prescription for DONEKA 5 mg TABLETS
Package Leaflet: Information for the User
Doneka 5mg tablets
Lisinopril
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet:
Doneka belongs to a group of medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors).
Doneka is indicated for:
Do not take Doneka if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Doneka.
Be especially careful with Doneka:
In all these cases, inform your doctor as you may need a dose adjustment or to stop taking Doneka.
Stop taking Doneka and seek medical attention immediately if you have difficulty breathing or swallowing with or without swelling of the face, lips, tongue and/or throat.
Inform your doctor if you are going to be hospitalized for surgery. Tell your doctor or dentist that you are taking Doneka before they administer a local or general anesthetic.
Children
Doneka is not recommended for use in children as the information on safety and efficacy in this age group is limited.
Other medicines and Doneka
Tell your doctor or pharmacist if you are taking, or have recently taken, any other medicines, including those obtained without a prescription.
Note that these instructions may also apply to medicines that have been used before or may be used after.
Certain medicines may interact with Doneka. In these cases, it may be necessary to change the dose or interrupt treatment with one of them.
It is important that you inform your doctor if you are taking or have recently taken any of the following medicines:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Normally, your doctor will advise you to stop taking lisinopril before you become pregnant or as soon as you know you are pregnant, and will recommend that you take another medicine instead of lisinopril. Lisinopril is not recommended in the first months of pregnancy, and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to the baby if used during this period (see section on pregnancy and breastfeeding).
Lisinopril is not recommended for mothers who are breastfeeding, and your doctor may choose another treatment for you if you want to breastfeed your baby, especially if it is a newborn or premature baby.
Driving and using machines
Doneka tablets are unlikely to affect your ability to drive or use machines; however, if you notice symptoms of dizziness or fatigue, do not perform tasks that require special attention until you know how you tolerate the medicine.
Follow exactly the instructions of administration of the medicine contained in this leaflet or as indicated by your doctor. In case of doubt, ask your doctor or pharmacist. Remember to take your medicine.
Your doctor will indicate how many tablets you should take per day and the duration of your treatment with Doneka. Do not stop treatment before.
The recommended dose is:
Adults
The usual initial recommended dose is 10 mg once a day.
The usual long-term dose is 20 mg once a day.
The usual initial recommended dose is 2.5 mg once a day.
The usual long-term dose is 5 mg up to a maximum of 35 mg once a day.
The usual initial recommended dose is 5 mg on the first and second day after the infarction, followed by 10 mg once a day.
The usual dose is 10 mg or 20 mg once a day.
Patient with renal function impairment
Your doctor will adjust the dose.
Method of administration:
If you think the action of Doneka is too strong or too weak, consult your doctor or pharmacist.
If you take more Doneka than you should:
If you take more Doneka than you should, consult your doctor or pharmacist immediately.
The most frequent symptoms in case of overdose are: hypotension, shock, renal failure, hyperventilation, tachycardia, palpitations, bradycardia, dizziness, anxiety, and cough.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service. Phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Doneka:
Do not take a double dose to make up for the forgotten dose, and wait for the next administration.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been described according to the following frequency categories:
Frequent:less than 1 in 10 but more than 1 in 100 patients
Uncommon:less than 1 in 100 but more than 1 in 1,000 patients
Rare:less than 1 in 1,000 patients but more than 1 in 10,000 patients
Very rare:less than 1 in 10,000 patients
Blood and lymphatic system disorders: | |
Rare: | decrease in hemoglobin (a blood protein), decrease in hematocrit (proportion of cells in the blood). |
Very rare: | bone marrow depression, anemia, thrombocytopenia (greater tendency to bruise), changes in some blood cells or components. |
Metabolic and nutritional disorders: | |
Very rare: | decrease in blood glucose. |
Nervous system and psychiatric disorders: | |
Frequent: | dizziness, headache |
Uncommon: | mood changes, tingling and/or numbness of certain limbs, vertigo, changes in taste, sleep disorders. |
Rare: | mental confusion. |
Cardiac and vascular disorders: | |
Frequent: | dizziness or lightheadedness when standing up quickly. |
Uncommon: | myocardial infarction or stroke, palpitations, rapid heartbeats, numbness and spasms in the fingers, followed by heat and pain (Raynaud's phenomenon). |
Respiratory disorders: | |
Frequent | Cough |
Uncommon: | Rhinitis. |
Very rare: | Shortness of breath, sinusitis, inflammation of the lungs |
Gastrointestinal disorders: | |
Frequent: | diarrhea, vomiting. |
Uncommon: | nausea, abdominal pain and indigestion. |
Rare: | dry mouth. |
Very rare: | inflammation of the liver or pancreas, jaundice (yellowing of the skin and/or eyes). |
Skin disorders: | |
Uncommon: | rash, itching. |
Rare: | intense skin itching (with hives), hair loss, psoriasis, allergic reaction (angioedema) characterized by swelling of the face, limbs, lips, tongue and/or larynx. |
Very rare: | sweating, severe skin disorders (whose symptoms may include redness, blisters, and peeling). |
Kidney and urinary disorders: | |
Frequent: | changes in kidney function. |
Rare: | increase in urea in the urine, acute renal failure. |
Very rare: | pain or inability to urinate. |
Reproductive system and breast disorders: | |
Uncommon: | impotence. |
Rare: | breast development in males. |
General disorders: | |
Uncommon: | fatigue, tiredness. |
Laboratory tests: | |
Uncommon: | increase in blood urea, increase in blood creatinine, increase in liver enzymes, increase in blood potassium. |
Rare: | increase in blood bilirubin, decrease in blood sodium. |
If you notice any side effects not mentioned in this leaflet, or if any of the side effects gets serious, or if you notice any side effects not mentioned in this leaflet, tell your doctor or pharmacist.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Doneka
Appearance of the product and pack contents
Doneka 5 mg is presented in the form of orange, round, biconvex tablets with a score line on one face and the mark "5" on the other. Each pack contains 60 tablets.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Manufacturer:
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Date of last revision of this leaflet: September 2016
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of DONEKA 5 mg TABLETS in November, 2025 is around 3.4 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DONEKA 5 mg TABLETS – subject to medical assessment and local rules.